BIOREGENX INC. (BRGX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BRGX Annual Balance Sheets →
The table below presents a historical view of BIOREGENX INC.'s balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent0.05
Cash & Short-term Investments0.00
Accounts receivable0.02
Inventories0.09
Total loans net0.01
Total Current Assets0.19
Equipment/Property/Plant Net0.15
Intangible Assets0.00
Other Assets, Noncurrent0.00
Total Assets0.34
Liabilities
Accounts Payable0.70
Accrued Liabilities, Current0.39
Short-term Debt0.95
Deferred Liability and Revenue0.06
Total Current Liabilities3.99
Long-term debt0.18
Long-term Debt Convertible0.00
Total Long-term Debt0.18
Other liabilities, Noncurrent2.59
Total Liabilities4.87
Stockholders' Equity
Common Stock Value0.97
Additional Paid In Capital Common Stock31.64
Retained Earnings / Accumulated Deficit-37.14
Accumulated Other Comprehensive Income0.00
Other Equity0.00
Common Stockholder's Equity-4.53
Total Stockholder's Equity-4.53
Liabilities & Stockholder's Equity0.34
4 historic quarters locked

Sign in to unlock the full BIOREGENX INC. balance sheet history.

About Bioregenx Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-004178

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.